Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Feb 15, 2025; 16(2): 100395
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.100395
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.100395
L-arginine administration exacerbates myocardial injury in diabetics via prooxidant and proinflammatory mechanisms along with myocardial structural disruption
Rasha A Mansouri, Huda F Alshaibi, Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 22254, Jeddah, Saudi Arabia
Rasha A Mansouri, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdu laziz University, Al-Kharj 11942, Saudi Arabia
Esam M Aboubakr, Department of Pharmacology and Toxicology, Faculty of Pharmacy-South Valley University, Qena 83523, Egypt
Huda F Alshaibi, Stem Cell Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Adel M Ahmed, Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt
Author contributions: Aboubakr EM and Ahmed AM were responsible for statistical analysis of the data, drafted and revised the manuscript and contributed to the conception and design of this article; Mansouri RA and Alshaibi HF contributed to the case collection and database organization; Mansouri RA and Ahmed AM interpreted the results, have contributed equally to this work as co-first authors. They both played a critical role in literature reviews, data collection and analysis as well as composition writing. Aboubakr EM and Alshaibi HF have contributed equally to this work. They both provided guidance and supervision to the design of this study. All authors read and approved the final manuscript.
Supported by The Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia, No. IF2/PSAU/2022/03/23339.
Institutional review board statement: The Faculty of Pharmacy Ethical Committee at South Valley University has approved the research project, which provided by Dr/ Esam M. Aboubakr, which study the effect of L arginine administration on the cardiac muscle of diabetic rats.
Institutional animal care and use committee statement: This study was reviewed and approved by the Faculty of Pharmacy Ethical Committee at South Valley University (protocol # P.S.V.U 230) for the use of animals.
Conflict-of-interest statement: The authors declare that they have no Conflict of interest.
Data sharing statement: Raw data can be obtained by contacting the corresponding author.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Esam M Aboubakr, Doctor, PhD, Associate Professor, Department of Pharmacology and Toxicology, Faculty of Pharmacy-South Valley University, Qena-afaga Road, Qena 83523, Egypt. esam_pharma@svu.edu.eg
Received: August 15, 2024
Revised: October 2, 2024
Accepted: November 25, 2024
Published online: February 15, 2025
Processing time: 137 Days and 7.2 Hours
Revised: October 2, 2024
Accepted: November 25, 2024
Published online: February 15, 2025
Processing time: 137 Days and 7.2 Hours
Core Tip
Core Tip: L-arginine (L-Arg) is commonly used amino acid with many physiological effects, but its safety and pharmacological effects are not fully understood and still controversial. This study found that a dose of 0.5 g/kg of L-Arg appears to be the highest dose that can be safely administered without producing cardiac damage in diabetic rats. However, doses of 1 g/kg or higher can worsen myocardial damage by increasing blood glucose levels, inflammation, and oxidative stress. L-Arg can also reduce body weight and improve lipid levels in rats, but these benefits do not outweigh the injurious effects of high doses on the cardiac muscle.